Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-03 8:51 pm Purchase |
2024-12-31 | 13G | Universe Pharmaceuticals INC UPC |
SABBY MANAGEMENT LLC | 18,180 9.900% |
18,180 (New Position) |
Filing History |
| 2025-01-03 8:18 pm Purchase |
2024-12-31 | 13G | Volcon, Inc. VLCN |
SABBY MANAGEMENT LLC | 56,034 9.900% |
56,034 (New Position) |
Filing History |
| 2025-01-03 7:50 pm Purchase |
2024-12-31 | 13G | Applied DNA Sciences, Inc. APDN |
SABBY MANAGEMENT LLC | 104,484 10.000% |
104,484 (New Position) |
Filing History |
| 2025-01-03 7:25 pm Purchase |
2024-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ |
SABBY MANAGEMENT LLC | 69,555 9.900% |
69,555 (New Position) |
Filing History |
| 2025-01-03 6:16 pm Sale |
2024-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
SABBY MANAGEMENT LLC | 29,051 4.900% |
-191,612 (-86.83%) |
Filing History |
| 2025-01-03 5:59 pm Purchase |
2024-12-31 | 13G | Cyngn Inc. CYN |
SABBY MANAGEMENT LLC | 14,322 9.900% |
13,967 (+3936.54%) |
Filing History |
| 2025-01-03 5:35 pm Sale |
2024-12-31 | 13G | Phunware, Inc. PHUN |
SABBY MANAGEMENT LLC | 0 0.000% |
-200,132 (Position Closed) |
Filing History |
| 2025-01-03 5:19 pm Sale |
2024-12-31 | 13G | iBio, Inc. IBIO |
SABBY MANAGEMENT LLC | 19,250 0.200% |
-181,053 (-90.39%) |
Filing History |
| 2025-01-03 4:35 pm Sale |
2024-12-31 | 13G | TransGlobe Energy Corporation TGA |
SABBY MANAGEMENT LLC | 0 0.000% |
-5,338,587 (Position Closed) |
Filing History |
| 2025-01-03 4:17 pm Purchase |
2024-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
SABBY MANAGEMENT LLC | 36,135 4.900% |
34,823 (+2653.29%) |
Filing History |
| 2025-01-03 3:54 pm Sale |
2024-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
SABBY MANAGEMENT LLC | 60,325 4.900% |
-12,152 (-16.77%) |
Filing History |
| 2025-01-03 3:31 pm Purchase |
2024-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX |
SABBY MANAGEMENT LLC | 27,587 4.900% |
27,143 (+6116.33%) |
Filing History |
| 2025-01-03 2:56 pm Purchase |
2024-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP |
SABBY MANAGEMENT LLC | 13,063 0.700% |
11,436 (+703.06%) |
Filing History |
| 2025-01-03 2:12 pm Purchase |
2024-12-31 | 13G | Fangdd Network Group Ltd. DUO |
SABBY MANAGEMENT LLC | 1,280,488 4.900% |
1,280,381 (+1199503.78%) |
Filing History |
| 2025-01-03 1:38 pm Purchase |
2024-12-31 | 13G | GlucoTrack, Inc. GCTK |
SABBY MANAGEMENT LLC | 32,353 4.900% |
11,481 (+55.01%) |
Filing History |
| 2025-01-03 12:57 pm Sale |
2024-12-31 | 13G | Recon Technology, Ltd. RCON |
SABBY MANAGEMENT LLC | 0 0.000% |
-191,797 (Position Closed) |
Filing History |
| 2025-01-03 12:41 pm Sale |
2024-12-31 | 13G | Arcadia Biosciences, Inc. RKDA |
SABBY MANAGEMENT LLC | 68,111 4.900% |
-29,194 (-30.00%) |
Filing History |
| 2025-01-02 9:01 pm Sale |
2024-12-31 | 13G | Mobiquity Technologies, Inc. MOBQ |
SABBY MANAGEMENT LLC | 0 0.000% |
-144,867 (Position Closed) |
Filing History |
| 2025-01-02 8:40 pm Purchase |
2024-12-31 | 13G | Revelation Biosciences, Inc. REVB |
SABBY MANAGEMENT LLC | 26,062 4.900% |
25,222 (+3002.34%) |
Filing History |
| 2025-01-02 7:13 pm Sale |
2024-12-31 | 13G | TUANCHE LTD ADR TCXXXX |
SABBY MANAGEMENT LLC | 146,754 5.000% |
-2,237,959 (-93.85%) |
Filing History |